Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodø, Norway.
Radiat Oncol. 2007 Jun 5;2:20. doi: 10.1186/1748-717X-2-20.
The purpose of this proof-of-principle study was to test the ability of an intensity-modulated radiotherapy (IMRT) technique to reduce the radiation dose to the heart plus the left ventricle and a coronary artery. Radiation-induced heart disease might be a serious complication in long-term cancer survivors.
Planning CT scans from 6 female patients were available. They were part of a previous study of mediastinal IMRT for target volumes used in lymphoma treatment that included 8 patients and represent all cases where the left anterior descending coronary artery (LAD) could be contoured. We compared 6 MV AP/PA opposed fields to a 3D conformal 4-field technique and an optimised 7-field step-and-shoot IMRT technique and evaluated DVH's for several structures. The planning system was BrainSCAN 5.21 (BrainLAB, Heimstetten, Germany).
IMRT maintained target volume coverage but resulted in better dose reduction to the heart, left ventricle and LAD than the other techniques. Selective dose reduction could be accomplished, although not to the degree initially attempted. The median LAD dose was approximately 50% lower with IMRT. In 5 out of 6 patients, IMRT was the best technique with regard to heart sparing.
IMRT techniques are able to reduce the radiation dose to the heart. In addition to dose reduction to whole heart, individualised dose distributions can be created, which spare, e.g., one ventricle plus one of the coronary arteries. Certain patients with well-defined vessel pathology might profit from an approach of general heart sparing with further selective dose reduction, accounting for the individual aspects of pre-existing damage.
本原理验证研究旨在测试调强放疗(IMRT)技术降低心脏加左心室和冠状动脉辐射剂量的能力。辐射性心脏病可能是长期癌症幸存者的严重并发症。
6 名女性患者的计划 CT 扫描可用于研究。他们是以前纵隔调强放疗用于淋巴瘤治疗靶区的研究的一部分,该研究包括 8 名患者,代表可以勾画左前降支(LAD)的所有病例。我们比较了 6MV AP/PA 对向野和 3D 适形 4 野技术以及优化的 7 野步进式 IMRT 技术,并评估了几个结构的剂量体积直方图(DVH)。计划系统是 BrainSCAN 5.21(BrainLAB,德国海姆斯泰滕)。
IMRT 保持了靶区覆盖,但与其他技术相比,心脏、左心室和 LAD 的剂量降低效果更好。虽然不能达到最初尝试的程度,但可以实现选择性剂量降低。LAD 的中位剂量约降低了 50%。在 6 名患者中的 5 名中,IMRT 在保护心脏方面是最佳技术。
IMRT 技术能够降低心脏的辐射剂量。除了降低全心脏剂量外,还可以创建个体化的剂量分布,从而保护例如一个心室和一条冠状动脉。对于某些具有明确血管病理学的患者,通过全面保护心脏并进一步选择性降低剂量的方法可能会受益,同时考虑到现有损伤的个体方面。